<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mass drug administration for control of parasitic infections</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mass drug administration for control of parasitic infections</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mass drug administration for control of parasitic infections</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rojelio Mejia, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward T Ryan, MD, DTMH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H10826470"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Empiric deworming refers to use of anthelminthic drugs to reduce the prevalence of infection due to soil-transmitted helminths in endemic areas. Such reductions in prevalence are generally temporary; mass drug administration (MDA) interrupts parasite life cycles but does not halt them completely, and the risk for reinfection is high [<a href="#rid1">1,2</a>].</p><p>Areas with high prevalence of helminth infection require a number of public health measures beyond preventive treatment, including safe drinking water, basic sanitation, and health education [<a href="#rid3">3</a>].</p><p>Issues related to population deworming are discussed here; issues related to the epidemiology, clinical manifestations, diagnosis, and treatment of individual parasitic infections are discussed separately. (See related topics.)</p><p class="headingAnchor" id="H10826476"><span class="h1">EFFICACY</span></p><p class="headingAnchor" id="H2294633495"><span class="h2">Children</span><span class="headingEndMark"> — </span>Infection due to soil-transmitted helminths has been associated with morbidity including delays in growth and cognitive development, particularly among children 2 to 12 years of age [<a href="#rid1">1,4-6</a>]. Population deworming may be effective in reducing the prevalence of infection [<a href="#rid7">7</a>]; the degree of benefit depends on patient characteristics, regional parasite species, and burden of infection.</p><p>The data on efficacy for population deworming are mixed; overall, the evidence demonstrates that children with helminth infections have diminished growth rates compared with uninfected children and that population deworming can help mitigate this issue [<a href="#rid8">8-12</a>]. The greatest benefit of deworming appears to be among young children who undergo screening prior to treatment [<a href="#rid13">13</a>].</p><p>The World Health Organization (WHO) has stated that, overall, mass treatment is not beneficial at a population level, but the WHO continues to recommend this approach since studies suggest that the children who are infected do benefit [<a href="#rid14">14,15</a>]. Targeting testing and treatment would be most beneficial, but this approach is too costly in many regions.</p><p>Studies performed in India during the 1990s suggested that deworming of malnourished children one to five years of age was associated with average weight gain of nearly one kilogram [<a href="#rid8">8</a>], and targeting worming of this age group has been advocated based on high prevalence of geohelminth infection [<a href="#rid9">9</a>]. Another study among Ugandan children one to seven years of age treated with deworming pills also concluded an association between deworming and weight gain, although the analysis did not reflect that the children were randomized in geographic clusters rather than individually [<a href="#rid10">10</a>].</p><p>Subsequently, a 2012 meta-analysis including 42 trials noted no association between deworming and child cognition, school attendance, or school performance [<a href="#rid11">11</a>]. Evidence for improvement in weight, hemoglobin level, and cognition was greatest among children screened for helminth infection prior to treatment. </p><p>The largest single trial addressing population deworming was published in 2013; it included 1 million preschool children in north India treated every six months for five years [<a href="#rid12">12</a>]. This trial noted no effect on weight gain or mortality; decline in the levels of worm infestation was observed, and compliance with treatment was high. Although the majority of children had a relatively light burden of infection, these studies were corroborated in rural China (also in light infection intensity) with no improvement on nutrition after deworming [<a href="#rid12">12,16</a>].</p><p>Repeat analysis of a previous study [<a href="#rid17">17</a>] showing favorable outcomes with deworming projects in Kenya demonstrated agreement with reductions in worm infections, but did not demonstrate a significant increase in school attendance and noted only a modest improvement in nutritional status [<a href="#rid18">18,19</a>]. The repeat analysis used the original data but documented discrepancies that reduced the statistical significance of deworming benefits [<a href="#rid17">17-19</a>].</p><p class="headingAnchor" id="H4281278965"><span class="h2">Pregnant patients</span><span class="headingEndMark"> — </span>The efficacy for population deworming among pregnant patients is also mixed [<a href="#rid20">20</a>]. </p><p>A Cochrane review of six trials (including 7873 pregnant patients seen at antenatal clinics in Uganda, Nigeria, Peru, India, Sierra Leone, and Tanzania) concluded that, when used in settings with high prevalence of maternal helminthiasis, administration of a single dose of anthelminthics during the second trimester may reduce maternal anemia (risk ratio 0.85, 95% CI 0.72-1.00) and worm prevalence (trichuris: risk ratio 0.68, 95% CI 0.48-0.98; ascaris risk ratio 0.24, 95% CI 0.19-0.29) [<a href="#rid21">21</a>]. </p><p>Some studies have noted an association between deworming of pregnant patients (together with iron and <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> supplementation) and improved neonatal outcome with respect to increased birth weight and reduced infant mortality [<a href="#rid22">22-25</a>]. However, another study including more than 2000 patients in Uganda with low-intensity helminth infection noted no overall benefit of anthelminthics during pregnancy [<a href="#rid26">26</a>], and there was an increased risk of eczema among newborns [<a href="#rid27">27</a>]. A 2008 review noted data are insufficient to confirm the benefits of deworming on anemia in pregnancy [<a href="#rid28">28</a>]. </p><p>One study has noted an association between helminth infection in pregnancy and malaria in offspring, suggesting that helminth infection during pregnancy may increase the burden of childhood malaria morbidity [<a href="#rid29">29</a>]. In one study in Peru, mothers infected with soil-transmitted helminths who underwent postpartum deworming were noted to have infants with improved growth [<a href="#rid30">30</a>].</p><p>It has been hypothesized that immune responses evoked by helminth infection may influence clinical susceptibility to malaria [<a href="#rid31">31,32</a>]. One randomized trial among 2436 children in Kenya noted that repeated deworming does not alter risk of clinical malaria or malaria parasitemia [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H10826579"><span class="h1">PARASITE TARGETS</span><span class="headingEndMark"> — </span>For circumstances in which MDA is felt to be warranted, reasonable target parasite species include the following intestinal helminths: </p><p class="bulletIndent1"><span class="glyph">●</span><em>Ascaris lumbricoides</em></p><p class="bulletIndent1"><span class="glyph">●</span><em>Ancylostoma duodenale</em></p><p class="bulletIndent1"><span class="glyph">●</span><em>Necator americanus</em></p><p class="bulletIndent1"><span class="glyph">●</span><em>Strongyloides stercoralis</em></p><p class="bulletIndent1"><span class="glyph">●</span><em>Trichuris trichiura</em></p><p></p><p>Nematode (roundworm) infections include <em>A. lumbricoides</em> (the cause of ascariasis),<em> A. duodenale</em> and <em>N. americanus</em> (the causes of hookworm), <em>S. stercoralis</em> (the cause of strongyloidiasis), and <em>T. trichiura</em> (the cause of trichuriasis) [<a href="#rid34">34</a>]. Nematodes are transmitted via cutaneous penetration or the fecal-oral route. Population deworming in areas where nematodes are endemic may be warranted among children who have undergone screening, even though reinfection rates are high [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/d/html/5673.html" rel="external">"Ascariasis"</a> and  <a class="medical medical_review" href="/d/html/5721.html" rel="external">"Hookworm infection"</a> and  <a class="medical medical_review" href="/d/html/5714.html" rel="external">"Strongyloidiasis"</a>.)</p><p>Empiric deworming is not an accepted prevention method for most regions with endemic cestode (tapeworm) infections (such as taeniasis, diphyllobothriasis, and hymenolepiasis) [<a href="#rid36">36</a>]. These infections are transmitted via contaminated food; prevention measures generally consist of controlling animal vectors, sanitation, and hygiene [<a href="#rid36">36,37</a>]. Population deworming may be useful for short-term control of transmission in some circumstances [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/5685.html" rel="external">"Tapeworm infections"</a>.)</p><p>Issues related to MDA for control of schistosomiasis are discussed separately. (See  <a class="medical medical_review" href="/d/html/5705.html" rel="external">"Schistosomiasis: Treatment and prevention", section on 'Control and prevention'</a>.)</p><p>Issues related to mass treatment for filariasis are discussed separately (see  <a class="medical medical_review" href="/d/html/5683.html" rel="external">"Onchocerciasis", section on 'Mass treatment'</a> and  <a class="medical medical_review" href="/d/html/5680.html" rel="external">"Lymphatic filariasis: Treatment and prevention", section on 'Mass treatment'</a>).</p><p class="headingAnchor" id="H10826524"><span class="h1">CLINICAL APPROACH</span></p><p class="headingAnchor" id="H3256607398"><span class="h2">Patient groups to target</span><span class="headingEndMark"> — </span>The greatest benefit of deworming has been among young children who undergo screening prior to treatment. </p><p>In general, pregnant women should undergo diagnostic evaluation with stool examination for ova and parasites, and treatment should be administered for pathogens identified (in lieu of empiric therapy) [<a href="#rid39">39</a>]. Empiric treatment may be reasonable for HIV-infected pregnant women [<a href="#rid40">40</a>]; further study is needed. </p><p>Evidence is weakest for routine deworming among nonpregnant adults in regions with endemic geohelminths.</p><p class="headingAnchor" id="H2413731809"><span class="h2">Logistics of administration</span><span class="headingEndMark"> — </span>The optimal approach to MDA is uncertain; modalities include community-based or school-based programs. A community-based approach may be more effective in reducing parasite prevalence than school-based administration [<a href="#rid41">41,42</a>], but school-based administration is logistically easier, less expensive, and has been shown to have some efficacy in reducing parasite prevalence [<a href="#rid43">43</a>]. </p><p>In a cluster-randomized trial including 150,000 Kenyan households, <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> was administered via annual school-based treatment targeting 2 to 14 year olds or via community-wide treatment targeting all ages (administered annually or biannually) [<a href="#rid41">41</a>]. After 24 months, the reduction in hookworm prevalence was greater in areas of community-wide treatment than in areas of school-based treatment (risk ratio 0.59 [95% CI 0.42-0·83] for annual community-wide treatment; risk ratio 0.46 [95% CI 0.33-0·63] for biannual community-wide treatment). No adverse events related to albendazole were reported. </p><p class="headingAnchor" id="H1436712642"><span class="h2">Deworming regimens</span><span class="headingEndMark"> — </span>Anthelminthic agents should be selected for activity against regional helminth species and to minimize adverse effects.</p><p>In the absence of detailed information regarding the predominant regional helminth species, a deworming regimen consisting of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> (400 mg orally once on empty stomach) and <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> (200 mcg/kg orally once) may be administered. Issues related to pregnancy are discussed below. (See <a class="local">'Pregnancy considerations'</a> below.)</p><p><a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">Ivermectin</a> should not be used empirically among populations at risk of loaiasis in Africa. Albendazole-ivermectin has efficacy for reduction of infection due to <em>A. lumbricoides</em>,<em> Enterobius vermicularis</em>, hookworm, <em>S. stercoralis</em>,<em> </em>and<em> T. trichiura</em>. Drug administration should be repeated at 6- to 12-month intervals with assessment of egg-reduction rates [<a href="#rid44">44</a>].</p><p>When possible, deworming regimens should be tailored to the predominant regional helminth species, as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ascariasis and/or hookworm</strong> - In regions known to have a high burden of ascariasis and/or hookworm, treatment consists of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> (children or nonpregnant adults: 400 mg orally once on empty stomach) or <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> (children or nonpregnant adults: 500 mg orally once). Ascariasis cure rates with these drugs are 96 to 100 percent; hookworm cure rates are 72 to 80 percent [<a href="#rid45">45,46</a>]. </p><p></p><p class="bulletIndent1">For pregnant patients, a reasonable alternative regimen is <a class="drug drug_general" data-topicid="9835" href="/d/drug information/9835.html" rel="external">pyrantel pamoate</a> (11 mg/kg orally once for ascariasis; 11 mg/kg once daily for three days for hookworm). Issues related to use of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> and <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> in pregnancy are discussed below. (See <a class="local">'Pregnancy considerations'</a> below.)</p><p></p><p class="bulletIndent1">Retreatment at 6- or 12-month intervals is appropriate [<a href="#rid47">47</a>]. Retreatment should be based on prevalence of helminthic infection in the population. Populations in high-risk areas (&gt;50 percent prevalence) should receive retreatment at 6 months, populations in moderate-risk areas (between 20 and 50 percent prevalence) every 12 months, and retreatment of populations in areas with less than 20 percent prevalence is usually not indicated [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Strongyloidiasis</strong> - In regions known to have a high burden of strongyloidiasis (tropical and subtropical regions), treatment consists of <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> (adults and children &gt;15 kg: 200 mcg/kg orally once; children &lt;2 years or &lt;15 kg: contraindicated); the cure rate is 97 percent [<a href="#rid48">48</a>]. <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">Albendazole</a> (adults: 400 mg orally on empty stomach twice daily for 7 days; children 400 mg orally on empty stomach twice daily for 7 days) is an alternative choice; the cure rate is 63 percent [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1">For pregnant patients, mass treatment should be deferred until after delivery, and breast feeding should be suspended during treatment.</p><p></p><p class="bulletIndent1">Issues related to <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> contraindications are discussed below. (See <a class="local">'Contraindications to ivermectin'</a> below.)</p><p></p><p class="bulletIndent1">Deworming for strongyloidiasis is important when considering complications with hyperinfection and disseminated strongyloidiasis. Mass administration of <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> in other control programs such as those targeting scabies have also resulted in a decrease prevalence of strongyloidiasis in target populations [<a href="#rid49">49,50</a>].  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trichuriasis</strong> - In regions known to have a high burden of trichuriasis, treatment consists of a combination of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> and <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> [<a href="#rid46">46,51,52</a>]. Retreatment at 6- or 12-month intervals is appropriate [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1">Issues related to pregnancy and <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> contraindications are discussed below. (See <a class="local">'Pregnancy considerations'</a> below and <a class="local">'Contraindications to ivermectin'</a> below.)</p><p></p><p class="bulletIndent1">One study including 450 children with trichuriasis noted that treatment with oxantel pamoate (20 mg/kg single dose) and <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> (400 mg single dose) resulted in higher cure rates than albendazole or <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> alone (31 and 42 percent, respectively); the former regimen is reasonable in regions where available [<a href="#rid53">53</a>]. </p><p></p><p class="headingAnchor" id="H4002218903"><span class="h2">Pregnancy considerations</span><span class="headingEndMark"> — </span>For pregnant patients in areas where the prevalence of hookworm and/or trichuriasis is ≥20 percent and the prevalence of anemia in pregnancy is ≥40 percent, we are in agreement with the World Health Organization, which favors administration of anthelminthic treatment after the first trimester [<a href="#rid54">54</a>]. In such cases, treatment consists of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> (400 mg single dose) or <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> (500 mg single dose).</p><p>Breast feeding should be suspended during the use of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> or <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> due to high drug levels in breast milk.</p><p><a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">Ivermectin</a> should not be administered to pregnant or lactating women.</p><p class="headingAnchor" id="H153194121"><span class="h2">Contraindications to ivermectin</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">Ivermectin</a> should not be administered to pregnant women, children &lt;2 years or &lt;15 kg, patients with liver disease, or patients in western Africa who are at risk for <em>Loa loa</em> infection [<a href="#rid55">55,56</a>]. Breast feeding should be suspended during the use of ivermectin due to high drug levels in breast milk.</p><p>Other issues related to anthelminthic drugs, including adverse effects, are discussed separately. (See  <a class="medical medical_review" href="/d/html/487.html" rel="external">"Anthelminthic therapies"</a>.)</p><p class="headingAnchor" id="H3355899350"><span class="h1">ADHERENCE</span><span class="headingEndMark"> — </span>Important barriers for gaps in implementation of MDA include lack of adequate drug delivery and insufficient health education. In one study of MDA in Uganda, factors associated with reduced likelihood of MDA participation included lower socioeconomic standing, membership in a religious or underrepresented ethnic group, longer residence in a location, and lack of a household latrine [<a href="#rid57">57</a>]. Other factors included relatively high intensity of <em>S. mansoni</em> infection and high hookworm prevalence.</p><p class="headingAnchor" id="H10826572"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Population deworming refers to empiric use of anthelminthic drugs to reduce the prevalence of infection due to soil-transmitted helminths in endemic areas. Such reductions in prevalence are generally temporary; mass drug administration interrupts parasite life cycles but does not halt them completely, and the risk for reinfection is high. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The greatest benefit of deworming appears to be among young children who undergo screening prior to treatment. In general, diagnostic evaluation with stool examination for ova and parasites should be performed for such patients, with administration of treatment for pathogens identified. (See <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reasonable target intestinal helminth species for deworming include <em>Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, Strongyloides stercoralis,</em> and<em> Trichuris trichiura</em>.<em> </em>(See <a class="local">'Parasite targets'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anthelminthic agents should be selected for activity against regional helminth species and to minimize adverse effects. In the absence of detailed information regarding the predominant regional helminth species, a deworming regimen consisting of <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> and <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> may be administered. Drug administration should be repeated at 6- to 12-month intervals with monitoring for decreasing prevalence of infection. Ivermectin should not be used empirically among populations at risk of loaiasis in Africa. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For pregnant patients in areas where the prevalence of hookworm and/or trichuriasis is ≥20 percent and the prevalence of anemia in pregnancy is ≥40 percent, we suggest administration of anthelminthic treatment after the first trimester (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>); regimens include <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> or <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a>. (See <a class="local">'Pregnancy considerations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">Ivermectin</a> should not be administered to pregnant women, children &lt;2 years of age or &lt;15 kg, patients with liver disease, or patients in western Africa who are at risk for <em>Loa loa</em> infection. (See <a class="local">'Contraindications to ivermectin'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Hotez PJ. Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and Their Impact on Global Health and Development, 2nd ed, American Society for Microbiology Press, Washington, DC 2013.</li><li><a class="nounderline abstract_t">Massara CL, Enk MJ. Treatment options in the management of Ascaris lumbricoides. Expert Opin Pharmacother 2004; 5:529.</a></li><li class="breakAll">Neglected tropical diseases: World Health Assembly REsolution WHA66.12. http://www.who.int/neglected_diseases/mediacentre/WHA_66.12_Eng.pdf (Accessed on February 13, 2014).</li><li><a class="nounderline abstract_t">Bundy DA, Walson JL, Watkins KL. Worms, wisdom, and wealth: why deworming can make economic sense. Trends Parasitol 2013; 29:142.</a></li><li><a class="nounderline abstract_t">Petri WA Jr, Miller M, Binder HJ, et al. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest 2008; 118:1277.</a></li><li><a class="nounderline abstract_t">Olds GR. Deworming the world. Trans Am Clin Climatol Assoc 2013; 124:265.</a></li><li><a class="nounderline abstract_t">Clarke NE, Clements AC, Doi SA, et al. Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis. Lancet 2017; 389:287.</a></li><li><a class="nounderline abstract_t">Awasthi S, Peto R, Pande VK, et al. Effects of deworming on malnourished preschool children in India: an open-labelled, cluster-randomized trial. PLoS Negl Trop Dis 2008; 2:e223.</a></li><li><a class="nounderline abstract_t">Awasthi S, Verma T, Kotecha PV, et al. Prevalence and risk factors associated with worm infestation in pre-school children (6-23 months) in selected blocks of Uttar Pradesh and Jharkhand, India. Indian J Med Sci 2008; 62:484.</a></li><li><a class="nounderline abstract_t">Alderman H, Konde-Lule J, Sebuliba I, et al. Effect on weight gain of routinely giving albendazole to preschool children during child health days in Uganda: cluster randomised controlled trial. BMJ 2006; 333:122.</a></li><li><a class="nounderline abstract_t">Taylor-Robinson DC, Maayan N, Soares-Weiser K, et al. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 2012; :CD000371.</a></li><li><a class="nounderline abstract_t">Awasthi S, Peto R, Read S, et al. Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial. Lancet 2013; 381:1478.</a></li><li><a class="nounderline abstract_t">Taylor-Robinson DC, Maayan N, Soares-Weiser K, et al. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance. Cochrane Database Syst Rev 2015; :CD000371.</a></li><li class="breakAll">World Health Organization. GUIDELINE: PREVENTIVE CHEMOTHERAPY
TO CONTROL SOIL-TRANSMITTED HELMINTH INFECTIONS IN AT-RISK POPULATION GROUPS. http://apps.who.int/iris/bitstream/10665/258983/1/9789241550116-eng.pdf?ua=1. (Accessed on December 05, 2017).</li><li><a class="nounderline abstract_t">Hawkes N. WHO advises blanket anti-worming treatment for children despite lack of benefit. BMJ 2017; 359:j4589.</a></li><li><a class="nounderline abstract_t">Liu C, Lu L, Zhang L, et al. Effect of Deworming on Indices of Health, Cognition, and Education among Schoolchildren in Rural China: A Cluster-Randomized Controlled Trial. Am J Trop Med Hyg 2017.</a></li><li><a class="nounderline abstract_t">Miguel E, Kremer M. Worms: Identifying impacts on education and health in the presence of treatment externalities. Econometrica 2004; 72:159.</a></li><li><a class="nounderline abstract_t">Aiken AM, Davey C, Hargreaves JR, Hayes RJ. Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a pure replication. Int J Epidemiol 2015; 44:1572.</a></li><li><a class="nounderline abstract_t">Davey C, Aiken AM, Hayes RJ, Hargreaves JR. Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized stepped-wedge trial. Int J Epidemiol 2015; 44:1581.</a></li><li><a class="nounderline abstract_t">Salam RA, Haider BA, Humayun Q, Bhutta ZA. Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy. Cochrane Database Syst Rev 2015; :CD005547.</a></li><li><a class="nounderline abstract_t">Salam RA, Das JK, Bhutta ZA. Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy. Cochrane Database Syst Rev 2021; 5:CD005547.</a></li><li><a class="nounderline abstract_t">Christian P, Khatry SK, West KP Jr. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 2004; 364:981.</a></li><li><a class="nounderline abstract_t">Larocque R, Casapia M, Gotuzzo E, et al. A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health 2006; 11:1485.</a></li><li><a class="nounderline abstract_t">Casey GJ, Sartori D, Horton SE, et al. Weekly iron-folic acid supplementation with regular deworming is cost-effective in preventing anaemia in women of reproductive age in Vietnam. PLoS One 2011; 6:e23723.</a></li><li><a class="nounderline abstract_t">Passerini L, Casey GJ, Biggs BA, et al. Increased birth weight associated with regular pre-pregnancy deworming and weekly iron-folic acid supplementation for Vietnamese women. PLoS Negl Trop Dis 2012; 6:e1608.</a></li><li><a class="nounderline abstract_t">Ndibazza J, Muhangi L, Akishule D, et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis 2010; 50:531.</a></li><li><a class="nounderline abstract_t">Mpairwe H, Webb EL, Muhangi L, et al. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol 2011; 22:305.</a></li><li><a class="nounderline abstract_t">Brooker S, Hotez PJ, Bundy DA. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis 2008; 2:e291.</a></li><li><a class="nounderline abstract_t">Ndibazza J, Webb EL, Lule S, et al. Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda. J Infect Dis 2013; 208:2007.</a></li><li><a class="nounderline abstract_t">Mofid LS, Casapía M, Aguilar E, et al. A Double-Blind Randomized Controlled Trial of Maternal Postpartum Deworming to Improve Infant Weight Gain in the Peruvian Amazon. PLoS Negl Trop Dis 2017; 11:e0005098.</a></li><li><a class="nounderline abstract_t">Hartgers FC, Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol 2006; 28:497.</a></li><li><a class="nounderline abstract_t">Mwangi TW, Bethony JM, Brooker S. Malaria and helminth interactions in humans: an epidemiological viewpoint. Ann Trop Med Parasitol 2006; 100:551.</a></li><li><a class="nounderline abstract_t">Kepha S, Nuwaha F, Nikolay B, et al. Effect of Repeated Anthelminthic Treatment on Malaria in School Children in Kenya: A Randomized, Open-Label, Equivalence Trial. J Infect Dis 2016; 213:266.</a></li><li><a class="nounderline abstract_t">Jourdan PM, Lamberton PHL, Fenwick A, Addiss DG. Soil-transmitted helminth infections. Lancet 2018; 391:252.</a></li><li><a class="nounderline abstract_t">Hall A, Anwar KS, Tomkins AM. Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992; 339:1253.</a></li><li><a class="nounderline abstract_t">Gilman RH, Gonzalez AE, Llanos-Zavalaga F, et al. Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health 2012; 106:312.</a></li><li class="breakAll">Magill AJ, Ryan ET, Solomon T, Hill DR. Hunter's Tropical Medicine and Emerging Infectious Diseases, 9th ed, Saunders, Philadelphia 2012.</li><li><a class="nounderline abstract_t">Cruz M, Davis A, Dixon H, et al. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull World Health Organ 1989; 67:401.</a></li><li><a class="nounderline abstract_t">Savioli L, Crompton DW, Neira M. Use of anthelminthic drugs during pregnancy. Am J Obstet Gynecol 2003; 188:5.</a></li><li><a class="nounderline abstract_t">Ivan E, Crowther NJ, Mutimura E, et al. Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda. Clin Infect Dis 2015; 60:135.</a></li><li><a class="nounderline abstract_t">Pullan RL, Halliday KE, Oswald WE, et al. Effects, equity, and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: a cluster-randomised controlled trial. Lancet 2019; 393:2039.</a></li><li><a class="nounderline abstract_t">Clarke NE, Clements ACA, Amaral S, et al. (S)WASH-D for Worms: A pilot study investigating the differential impact of school- versus community-based integrated control programs for soil-transmitted helminths. PLoS Negl Trop Dis 2018; 12:e0006389.</a></li><li><a class="nounderline abstract_t">Mwandawiro C, Okoyo C, Kihara J, et al. Results of a national school-based deworming programme on soil-transmitted helminths infections and schistosomiasis in Kenya: 2012-2017. Parasit Vectors 2019; 12:76.</a></li><li class="breakAll">World Health Organization. Assessing the efficacy of anthelminthic drug against schistosomiasis and soil-transmitted helminthiases. http://apps.who.int/iris/bitstream/10665/79019/1/9789241564557_eng.pdf (Accessed on February 13, 2014).</li><li><a class="nounderline abstract_t">Vercruysse J, Behnke JM, Albonico M, et al. Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis 2011; 5:e948.</a></li><li><a class="nounderline abstract_t">Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ 2017; 358:j4307.</a></li><li class="breakAll">World Health Organization. Eliminating Soil-Transmitted Helminthiases as a Public Health Problem in Children: Progress Report 2001–2010 and Strategic Plan 2011–2020. World Health Organization Press, Geneva, Switzerland 2012. Available at: http://whqlibdoc.who.int/publications/2012/9789241503129_eng.pdf.</li><li><a class="nounderline abstract_t">Suputtamongkol Y, Premasathian N, Bhumimuang K, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis 2011; 5:e1044.</a></li><li><a class="nounderline abstract_t">Amato VS, Tuon FF. Mass Drug Administration for the Control of Strongyloides stercoralis Infection: Progress and Challenges. Clin Infect Dis 2020; 71:3229.</a></li><li><a class="nounderline abstract_t">Marks M, Gwyn S, Toloka H, et al. Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children. Clin Infect Dis 2020; 71:3226.</a></li><li><a class="nounderline abstract_t">Knopp S, Mohammed KA, Speich B, et al. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis 2010; 51:1420.</a></li><li><a class="nounderline abstract_t">Belizario VY, Amarillo ME, de Leon WU, et al. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ 2003; 81:35.</a></li><li><a class="nounderline abstract_t">Speich B, Ame SM, Ali SM, et al. Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med 2014; 370:610.</a></li><li class="breakAll">World Health Organization. Deworming in pregnant women. https://www.who.int/elena/titles/deworming_pregnancy/en/ (Accessed on July 23, 2021).</li><li><a class="nounderline abstract_t">Gardon J, Gardon-Wendel N, Demanga-Ngangue, et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997; 350:18.</a></li><li><a class="nounderline abstract_t">Boussinesq M, Gardon J, Gardon-Wendel N, et al. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 1998; 58:461.</a></li><li><a class="nounderline abstract_t">Chami GF, Kontoleon AA, Bulte E, et al. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda. Clin Infect Dis 2016; 62:200.</a></li></ol></div><div id="topicVersionRevision">Topic 91857 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hotez PJ. Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and Their Impact on Global Health and Development, 2nd ed, American Society for Microbiology Press, Washington, DC 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15013922" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Treatment options in the management of Ascaris lumbricoides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15013922" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Treatment options in the management of Ascaris lumbricoides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23332661" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Worms, wisdom, and wealth: why deworming can make economic sense.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18382740" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Enteric infections, diarrhea, and their impact on function and development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23874034" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Deworming the world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27979381" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18414647" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Effects of deworming on malnourished preschool children in India: an open-labelled, cluster-randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19265242" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prevalence and risk factors associated with worm infestation in pre-school children (6-23 months) in selected blocks of Uttar Pradesh and Jharkhand, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16790460" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Effect on weight gain of routinely giving albendazole to preschool children during child health days in Uganda: cluster randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22786473" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23498850" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26202783" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26202783" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28978549" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : WHO advises blanket anti-worming treatment for children despite lack of benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28093533" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effect of Deworming on Indices of Health, Cognition, and Education among Schoolchildren in Rural China: A Cluster-Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Worms: Identifying impacts on education and health in the presence of treatment externalities</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26203169" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a pure replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26203171" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized stepped-wedge trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26087057" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33998661" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15364190" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17002722" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21931611" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Weekly iron-folic acid supplementation with regular deworming is cost-effective in preventing anaemia in women of reproductive age in Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22509421" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Increased birth weight associated with regular pre-pregnancy deworming and weekly iron-folic acid supplementation for Vietnamese women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20067426" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21255083" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18820740" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hookworm-related anaemia among pregnant women: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23904293" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28056024" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A Double-Blind Randomized Controlled Trial of Maternal Postpartum Deworming to Improve Infant Weight Gain in the Peruvian Amazon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16965285" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Co-infection of helminths and malaria: modulation of the immune responses to malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16989681" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Malaria and helminth interactions in humans: an epidemiological viewpoint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26170395" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effect of Repeated Anthelminthic Treatment on Malaria in School Children in Kenya: A Randomized, Open-Label, Equivalence Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28882382" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Soil-transmitted helminth infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1349668" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23265557" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prevention and control of Taenia solium taeniasis/cysticercosis in Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23265557" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prevention and control of Taenia solium taeniasis/cysticercosis in Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2805217" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548188" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Use of anthelminthic drugs during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25210019" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31006575" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effects, equity, and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: a cluster-randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29723193" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : (S)WASH-D for Worms: A pilot study investigating the differential impact of school- versus community-based integrated control programs for soil-transmitted helminths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30732642" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Results of a national school-based deworming programme on soil-transmitted helminths infections and schistosomiasis in Kenya: 2012-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30732642" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Results of a national school-based deworming programme on soil-transmitted helminths infections and schistosomiasis in Kenya: 2012-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21468309" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28947636" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28947636" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21572981" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32421778" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Mass Drug Administration for the Control of Strongyloides stercoralis Infection: Progress and Challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32421762" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21062129" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12640474" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24521107" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Oxantel pamoate-albendazole for Trichuris trichiura infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24521107" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Oxantel pamoate-albendazole for Trichuris trichiura infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217715" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9574793" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26409064" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
